Lysins-Very Effective at Target Killing at Bacteria
Lysigen has developed a staph lysin that will target the bacteria that causes the itching/infection associated with eczema. Lysigen will initially develop a hospital product (that can be stored at 4 degrees) and later a consumer product that can be stored at 37 degrees.
Lysigen has developed the first commercially viable c.acne lysin to treat and prevent acne. Lysigen will initially develop a hospital product that is combined with ClyO (a lysin that targets staph bacteria which also cause acne). This hospital product can be stored at 4 degrees. Later, Lysigen will launch a consumer product that can be stored at 37 degrees.